探秘好莱坞明星的传奇座驾：YUKON DENALI
YUKON DENALI 以其霸气的外观、强大的性能和极致的奢华，成为了好莱坞明星们的传奇座驾。它不仅是一款交通工具，更是一种身份与品味的象征。无论是在繁华的都市街头，还是在星光熠熠的红毯上，YUKON DENALI ...
Denali Therapeutics首席医疗官Carole Ho出售价值308,290美元的股票
根据提交给美国证券交易委员会的文件显示，Denali Therapeutics Inc. (NASDAQ:DNLI)的首席医疗官Carole Ho最近出售了公司的普通股。1月6日和7日，Ho总共出售了15,162股，获得308,290美元。售价在每股20.22美元至20.81美元之间。根据 InvestingPro ...
Denali股票维持买入评级，分析师强调2025年可能获批亨特综合征治疗药物
分析师评论了Denali最近的股价下跌，将其归因于更广泛的市场趋势，而非公司特定消息。Denali的股价回调反映了XBI生物技术指数的走势，被认为是整体投资组合定位转变的一部分，在高利率环境下，较大的基金可能减少了生物技术领域的敞口。
Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains
Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...
Yahoo6 天
Denali Reverses Its Fortunes With 'Too Early' Miss In ALS Treatment
On Monday, Denali Therapeutics Inc. (NASDAQ:DNLI) revealed topline results from an analysis of Regimen G of the Phase 2/3 HEALEY ALS Platform Trial evaluating DNL343 for amyotrophic lateral sclerosis.
ALS drugs from Denali, Calico come up short, marking setback for Healey trial
Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...
BioSpace7 天
Denali Suffers Another ALS Fail With Phase II/III Flop
Denali’s failure on Monday continues biopharma’s losing streak against amyotrophic lateral sclerosis. PTC Therapeutics and ...
Why biotech startup Tenvie sees promise in drugs from founders' old company
About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...
GMC Celebrates 25 Years Of The Denali
To commemorate the 25th anniversary of Denali, GMC is offering customers a special 25th Anniversary Denali Package available ...